类风湿关节炎心血管疾病预防的医疗质量:高脂血症筛查指南的依从性
基于加拿大不列颠哥伦比亚省1996至2006年人群类风湿关节炎队列随访至2010年,与匹配的普通人群对照比较高脂血症筛查指南依从性。类风湿关节炎组5587人贡献6993个5年资格期,对照组5613人贡献7208个资格期,血脂检测率分别为56.6%和59.5%,调整比值比为0.97(95%CI 0.90, 1.06)。作者结论为类风湿关节炎人群高脂血症筛查依从性差且与普通人群无差异。
要点
- 类风湿关节炎患者血脂筛查依从率56.6%,与普通人群59.5%相比无显著差异。
- 调整年龄和性别后,类风湿关节炎相对对照的依从比值比为0.97(95%CI 0.90, 1.06)。
- 2003年后类风湿关节炎筛查依从性仍仅65.8%,作者认为依从性差。
核心结论
- 作者结论为类风湿关节炎人群高脂血症筛查指南依从性差,且与普通人群无差异,尽管心血管疾病风险更高。
研究设计与样本
- 纵向研究,纳入1996至2006年不列颠哥伦比亚省所有流行类风湿关节炎病例组成的人群队列,随访至2010年,并设匹配的普通人群对照。
- 使用行政数据测量对普通人群指南的依从性(女性≥50岁和男性≥40岁每5年检测血脂),排除既往糖尿病、冠心病或高脂血症者。
- 依从性定义为5年资格期内至少一次血脂检测的资格期比例,采用卡方检验比较两组,采用广义估计方程模型调整年龄和性别估计比值比(95%CI),并计算每例患者平均依从率用Mann-Whitney U检验比较。
主要发现
- 分析纳入类风湿关节炎5587人贡献6993个5年资格期,对照5613人贡献7208个资格期。
- 血脂检测率在类风湿关节炎组为56.6%,对照组为59.5%,调整比值比(95%CI)为0.97(0.90, 1.06)。
- 类风湿关节炎相对普通人群筛查依从性随时间改善,但2003年后仍仅为65.8%。
- 每例患者平均(标准差)依从率类风湿关节炎组为56.6(47.2)%,对照组为59.5(46.6)%。
- 几乎所有血脂检测由家庭医生开具。
关键数值与推荐
- 普通人群指南筛查标准:女性≥50岁和男性≥40岁每5年检测血脂。
- 依从性测量排除既往糖尿病、冠心病或高脂血症个体。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate compliance with hyperlipidaemia screening guidelines for cardiovascular disease prevention in RA compared with the general population. METHODS: We conducted a longitudinal study of a population-based RA cohort including all prevalent cases in British Columbia between 1996 and 2006, followed up until 2010, with matched general population controls. Using administrative data, we measured compliance with general population guidelines (testing lipids every 5 years for women ⩾50 and men ⩾40), after excluding individuals with previous diabetes, coronary artery disease or hyperlipidaemia. Compliance was measured as the proportion of 5-year eligibility periods with one or more lipid test. Compliance rates in RA and controls were compared by Chi-square test. Odds ratio (95% CI) of compliance in RA (vs controls) was estimated using generalized estimating equation models, adjusting for age and sex. Mean compliance rate per patient was also calculated and compared using Mann-Whitney U test. RESULTS: Analyses included 5587 RA individuals and 5613 controls, contributing 6993 and 7208 5-year eligibility periods, respectively. Lipids were measured in 56.6 and 59.5% of eligibility periods in RA and controls, respectively [adjusted odds ratio (95% CI): 0.97 (0.90, 1.06)]. Screening improved over time in RA relative to the general population, but remained suboptimal even after 2003, at 65.8%. Mean (s.d.) compliance rate per patient was 56.6 (47.2)% for RA and 59.5 (46.6)% for controls. Family physicians ordered almost all the lipid tests. CONCLUSION: Compliance with general population guidelines for hyperlipidaemia screening in RA was poor and did not differ from the general population, despite a higher risk of cardiovascular diseases.
引用
- Schmidt TJ, Aviña-Zubieta JA, Sayre EC, et al. Quality of care for cardiovascular disease prevention in rheumatoid arthritis: compliance with hyperlipidemia screening guidelines. Rheumatology (Oxford). 2018. PMID: 29955871. doi:10.1093/rheumatology/key164
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。